thromboxanes has been researched along with Hypercalcemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oelz, O | 1 |
| Hubbard, WC; Maas, RL; Oates, JA; Roberts, LJ; Sweetman, BJ | 1 |
| Gerkens, JF; Maas, RL; Oates, JA; Roberts, LJ; Sweetman, BJ; Taber, DF | 1 |
1 review(s) available for thromboxanes and Hypercalcemia
| Article | Year |
|---|---|
The clinical significance of arachidonic acid metabolites.
Topics: Animals; Arachidonic Acids; Cardiovascular Diseases; Diabetes Mellitus; Diet; Drug Interactions; Ductus Arteriosus, Patent; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypercalcemia; Hypersensitivity; Infant, Newborn; Inflammation; Kidney Diseases; Lung Diseases; Male; Neoplasms; Pregnancy; Prostaglandin Antagonists; Prostaglandins; Reproduction; Thromboxanes | 1982 |
2 other study(ies) available for thromboxanes and Hypercalcemia
| Article | Year |
|---|---|
Clinical application of PG and TX metabolite quantification.
Topics: Epoprostenol; Humans; Hypercalcemia; Insulinoma; Mast-Cell Sarcoma; Neoplasms; Pancreatic Neoplasms; Prostaglandins; Thromboxanes; Thyroid Neoplasms | 1981 |
Metabolism of the prostaglandins and thromboxanes.
Topics: Animals; Epoprostenol; Half-Life; Humans; Hypercalcemia; Kinetics; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Thromboxanes | 1980 |